Fundz

Onco C4, Inc. reported raising in an initial SEC Form D filing, from an offering of $50 Million

PRIVATEJan 07, 2021$0 of $50M raised

Round Type

Venture

RockvilleBiotechnology

Quick answer

OncoC4 raised an undisclosed amount in a funding round, dated January 7, 2021. OncoC4 is based in Rockville, Maryland, United States.

How much did OncoC4 raise?
OncoC4 raised an undisclosed amount in a funding round on January 7, 2021.
What does OncoC4 do?
OncoC4 is a privately held, late-stage biopharmaceutical company engaged in the discovery and development of novel biologicals for treating cancer and immunological diseases.
Where is OncoC4 based and how big is it?
OncoC4 is based in Rockville, Maryland, United States. Fundz records about 66 employees.
Who are the decision-makers at OncoC4?
Fundz holds 1 contact at OncoC4. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as OncoC4 that raised within 45 days of this round, from Fundz verified event records.

  • Graviton BioScience raised $3.5M (Seed) on February 19, 2021.
  • Ensoma raised $129M on February 19, 2021.
  • SINGLE CELL TECHNOLOGY, INC. raised $2.1M (Seed) on February 19, 2021.
  • HeartSciences raised $1.1M (Seed) on February 19, 2021.
  • Trillium Renewable Chemicals raised $1.5M (Seed) on February 18, 2021.
  • Saliogen Therapeutics, Inc. raised $20M on February 18, 2021.

Who to call at OncoC4, and when

A new round usually means OncoC4 is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day OncoC4 raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OncoC4, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OncoC4. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OncoC4

Location

Rockville, Maryland, United States

About

OncoC4 is a privately held, late-stage biopharmaceutical company engaged in the discovery and development of novel biologicals for treating cancer and immunological diseases. Its pipeline features assets with first-in-class and best-in-class potential. AI-081 is a potentially best-in-class bispecific antibody candidate currently enrolling patients in a Phase 1/2 trial. OncoC4 also has a collaboration with BioNTech to co-develop gotistobart.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OncoC4 raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for OncoC4's next move

See what Strategic adds

OncoC4 raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.